Home workouts could help black men fight prostate cancer without surgery

NCT ID NCT05918263

Recruiting now Disease control Sponsor: Fred Hutchinson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 4 times

Summary

This study tests whether a 16-week home-based high-intensity interval training (HIIT) program can slow prostate cancer in Black men who are on active surveillance (monitoring the cancer without immediate treatment). The trial involves 68 participants who will use a stationary bike and heart rate monitor, with virtual supervision. The main goal is to see if exercise lowers PSA levels, a marker of prostate cancer activity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: High-intensity interval training (HIIT) exercise program
What this could lead to: If it works, this could show that regular exercise helps slow prostate cancer growth, offering a non-drug way to manage the disease for Black men on active surveillance.
What could go wrong: This is a small, early-phase trial with only 68 participants, so results may not apply broadly. Exercise may not significantly affect PSA levels, and the home-based program depends on participant adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma prostate neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER PROSTATIC NEOPLASMS

Contacts and locations

Locations

Beth Israel Deaconess Medical Center
COMPLETED

Boston, Massachusetts, 02215, United States
Brigham and Women's Hospital
COMPLETED

Boston, Massachusetts, 02215, United States
Dana-Farber Cancer Institute
COMPLETED

Boston, Massachusetts, 02215, United States
Fred Hutch/University of Washington Cancer Consortium
RECRUITING

Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.